Sponsored by the Rock Center for Corporate Governance and SVDX

7:30 – 8:00am Continental Breakfast

8:00 – 9:30am Program

With the rise of activist investors, the advent of proxy access, and continuous changes on the competitive landscape; focus and attention on board composition and succession planning has never been greater. Boards are under increasing pressure to assemble the right mix of leadership experience and skills not only to help their companies succeed today, but also to face inevitable curves ahead.

But how do businesses and boards strike the right balance? How can a board objectively assess what’s working and what’s not? Our distinguished panel will highlight best practices and processes and share their board succession planning experiences from real world examples:

• How do boards find and vet future candidates?
• What information and tools are companies using to help them through succession planning?
• How are boards handling the “problem child” director that everyone knows should be off the board?

Our Panel

Dan Cooperman is an attorney at DLA Piper, a fellow at the Rock Center for Corporate Governance, and a director at Molina Healthcare, Inc. Dan focuses his practice on corporate governance, board of directors issues, and the organization and management of a global legal department and global law firm. Dan has a nearly 40-year career in law and business, most notably serving as senior vice president and general counsel at Oracle under Larry Ellison and at Apple under Steve Jobs. He serves as a strategic advisor to Institutional Venture Partners, a premier late-stage venture capital firm, and its portfolio companies

Curt Crawford, PhD is president and CEO of XCEO.He is the author of two books: Corporate Rise: The X Principles of Extreme Personal Leadership and Compliance & Conviction: The Evolution of Enlightened Corporate Governance. Curt currently serves on the board of directors of Xylem Corp and ON Semiconductor. He previously served on the E. I. du Pont de Nemours board and has been nominated to board of Chemours, a new company created from DuPont’s Performance Chemicals businesses. He has also been a board member of ITT Corp, Agilysys, Lyondell Petrochemical, Sisters of Mercy Health Corporation, and DePaul University.

Jesse Wiley is director at John Wiley & Sons and has served as a member of the nominating and governance committee since 2012. With the chairman, he will be forming a new technology committee this fall. As part of the seventh generation of the Wiley family working in the company, he joined in 2003 playing various roles in marketing, editorial, digital product development, new market development in Asia, and currently in strategic business development and mergers and acquisitions. Jesse also helps manage Wiley family business governance affairs.

Moderator

As CEO and founder of Equilar, David Chun has led it since its inception to become one of the most respected and trusted names in the executive compensation industry. David has been recognized as one of the “100 Most Influential Players in Corporate Governance” by the National Association of Corporate Directors (NACD). David often speaks publicly on corporate governance and executive compensation matters, including events hosted by The Conference Board, Corporate Board Member, The HR Policy Association, NACD Directorship, NASDAQ OMX, NYSE Euronext, the Society of Corporate Secretaries and Governance Professionals and Stanford’s Directors’ College.

This program, like all SVDX programs, is subject to the Chatham House Rule.